These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pro and con of heparin-bonded circuits for cardiopulmonary bypass. Weiss BM; von Segesser LK J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):646-52. PubMed ID: 10527241 [No Abstract] [Full Text] [Related]
4. Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. Park CB; Suri RM; Burkhart HM; Greason KL; Dearani JA; Schaff HV; Sundt TM J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1028-35. PubMed ID: 20951254 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [TBL] [Abstract][Full Text] [Related]
6. A protocol-driven approach to cardiac reoperation reduces mortality and cardiac injury at the time of resternotomy. LaPar DJ; Ailawadi G; Harris DA; Hajzus VA; Lau CL; Kern JA; Kron IL Ann Thorac Surg; 2013 Sep; 96(3):865-70; discussion 870. PubMed ID: 23932322 [TBL] [Abstract][Full Text] [Related]
7. More biocompatibility in cardiopulmonary bypass for high-risk patients. Baufreton C Ann Thorac Surg; 2006 Feb; 81(2):790-1; author reply 791. PubMed ID: 16427917 [No Abstract] [Full Text] [Related]
8. Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke. Morimoto N; Henmi S; Yoshida M; Mukohara N J Thorac Cardiovasc Surg; 2012 Sep; 144(3):726-8. PubMed ID: 22541513 [No Abstract] [Full Text] [Related]
10. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987 [TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization. Mirow N; Zittermann A; Körperich H; Börgermann J; Koertke H; Knobl H; Gieseke J; Ostertun B; Coskun T; Kleesiek K; Burchert W; Gummert JF J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820 [TBL] [Abstract][Full Text] [Related]
12. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts. Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488 [TBL] [Abstract][Full Text] [Related]
13. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures. Taneja R; Cheng DC Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205 [No Abstract] [Full Text] [Related]
14. Heparin-induced thrombocytopenia type II after cardiac surgery: predictors and outcome. Assmann A; Boeken U; Feindt P; Schurr P; Akhyari P; Lichtenberg A Thorac Cardiovasc Surg; 2010 Dec; 58(8):463-7. PubMed ID: 21110268 [TBL] [Abstract][Full Text] [Related]
15. Redo sternotomy for cardiac reoperations using peripheral heparin-bonded cardiopulmonary bypass circuits without systemic heparinization: technique and results. Singh AK; Stearns G; Maslow A; Feng WC; Schwartz C J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):347-52. PubMed ID: 20801057 [TBL] [Abstract][Full Text] [Related]
16. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]